Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 9OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Cyclophosphamide 2067Radiotherapy 1986Cisplatin 1855Carboplatin 1559Gemcitabine 1454Paclitaxel 1320Bevacizumab 1318pembrolizumab 1236Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 978Magnetic Resonance Spectroscopy 969Nivolumab 936Rituximab 929Drug Therapy 914Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 815Blood Specimen Collection 815Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × estradiol, norethindrone drug combination × Clear all
NCT00919919 2009-06-12

Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen

Rabin Medical Center

Phase 2 Unknown
60 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡